A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms

Maturitas

Volumn 24, Issue 1-2, 1996, Pages 111-118

  Saure, A ^a   Hirvonen, E ^b   Milsom, I ^c   Christensen, A ^d   Damber, M G ^e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d TELEMARK HOSPITAL   (Norway)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NETA;

DESOGESTREL; ESTRADIOL; GESTAGEN; NORETHISTERONE; TRISEQUENS;

ADULT; ARTICLE; BREAKTHROUGH BLEEDING; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG MIXTURE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CYTOLOGY; ESTROGEN DEFICIENCY; FEMALE; FITNESS; HEADACHE; HOT FLUSH; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALAISE; MENOPAUSE; MULTICENTER STUDY; NERVOUSNESS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SWEATING; TABLET; VAGINA BLEEDING; VERTIGO;

ADMINISTRATION, ORAL; CLIMACTERIC; DESOGESTREL; DOUBLE-BLIND METHOD; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; NORETHINDRONE; PATIENT COMPLIANCE; PHYSICAL FITNESS; PLACEBOS; POSTMENOPAUSE; PROGESTERONE CONGENERS; SWEATING; UTERINE HEMORRHAGE;

EID: 0029996732     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(96)01029-8     Document Type: Article

References (25)

1. Persson I, Adami H-O, Bergkvist L, Lindgren A, Pettersson B, Hoover R, Schairer C. Risk of endometrial cancer after treatment with estrogens alone or in conjunction with progestogens results of a prospective study. Br Med J 1989; 298: 147-151.
2. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindram CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75: 1102-1109.
3. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. J Am Med Ass 1991; 265: 1861-1867.
4. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-1204.
5. Tikkanen MJ. Estrogens and progestins used in postmenopausal replacement therapy as modulators of serum lipoproteins. In Crepaldi G et al., eds. Atherosclerosis VIII. Amsterdam, Elsevier, 1989; 765-768.
6. Kuusi T, Nikkilä EA, Tikkanen MJ, Sipinen S. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein-2. Atherosclerosis 1985; 54: 251-262.
7. Fotherby K, Caldwell ADS. New progestogens in oral contraception. Contraception 1994; 49: 1-32.
8. Kloosterboer HJ, van Wayjen RGA, van den Ende A. Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism. Contraception 1986; 34: 135-144.
9. Kloosterboer HJ, Vonk-Noordegraaf CA, Turpijn EW. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives. Contraception 1988; 38: 325-332.
10. Cullberg G, Eriksson O, Knutsson F, Steffensen K. Desogestrel, a new progestational compound. Comparative study with lynestrenol, performed in ovariectomized women. Acta Obstet Gynecol Scand 1982, Suppl. 111: 13-19.
11. Marslew U, Overgaard K, Riis BJ, Christiansen C. New oestrogen/progestogen combinations. Long-term effects on bone and calcium metabolism in early postmenopausal women. In: Christiansen C, Overgaard K, eds. Osteoporosis 1990. Aalborg Aps 1990; 2: 1265-6.
12. Saure A, Hirvonen E, Viinikka L, Ylikorkala O. The effect of a novel sequential estradiol-desogestrel treatment on the bone in postmenopausal women. In: Christiansen C, Overgaard K, eds. Osteoporosis 1990. Aalborg Aps 1990; 2: 1068-1070.
13. Marslew U, Riis BJ, Christiansen C. Desogestrel in hormone replacement therapy long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Eur J Clin Invest 1991; 21: 601-607.
14. Saure A, Hirvonen E, Tikkanen MJ, Viinikka L, Ylikorkala O. A novel oestradiol desogestrel preparation for hormone replacement therapy effects on hormones, lipids, bone, climacteric symptoms and endometrium. Maturitas 1993; 16: 1-12.
15. Schlemmer A, Hassager C, Delmas PD, Christiansen C. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progestogen therapy. Clin Endocrinol 1994; 40: 777-782.
16. Saure A, Hirvonen E, Tikkanen M, Viinikka L, Ylikorkala O. Endocrine and metabolic effects of a novel estradiol-desogestrel treatment in postmeno-pausal women. Ninth International Congress of Endocrinology. Nice 1992; 476.
17. Haarbo J, Hassager C, Jensen SB, Riis BJ, Christiansen C. Serum lipids, lipo-proteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives. Am J Med 1991; 90: 584-589.
18. Haarbo J, Christiansen C. Treatment induced cyclic variations in serum lipids, lipoproteins, and apolipoproteins after 2 years of combined hormone replacement therapy exaggerated cyclic variations in smokers. Obstet Gynecol 1992; 80: 639-644.
19. Byrjalsen I, Thormann L, Meinecke B, Riis BJ, Christiansen C. Sequential estrogen and progestogen therapy Assessment of progestational effects on the postmenopausal endometrium. Obstet Gynecol 1992; 79: 523-528.
20. Bradley JW. Distribution-free Statistical Tests. Prentice-Hall, London 1968; 68-86.
21. Oden A, Wedel H. Arguments for Fisher''s permutation test. Ann Stat 1975; 3: 518-520.
22. Marslew U, Riis B, Christiansen C. Progestogens therapeutic and adverse effects in early post-menopausal women. Maturitas 1991; 13: 7-16.
23. Hellberg D, Nilsson S. Comparison of a triphasic estradiol/norethisterone acetate preparation with and without an estriol component in the treatment of climacteric complaints. Maturitas 1984; 5: 233-244.
24. Obel EB, Munk-Jensen N, Svenstrup B, Bennett P, Micic S, Henrik-Nielsen R, Pors Nielsen S, Gydesen H, Jensen BM. A two-year bouble-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment. Maturitas 1993; 16: 13-21.
25. Marslew U, Munk-Nielsen N, Nilas L, Riis BJ, Christiansen C. Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use. Maturitas 1994; 19: 225-237.